Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

ArQule and Acacia to develop novel drug candidates

Oct. 22, 1997

Megestrol + ibuprofen for cancer cachexia

Oct. 21, 1997

First launch for Yamanouchi bisphosphonate

Oct. 21, 1997

FDA approves Follistim for IVF and ovulation induction

Oct. 17, 1997

Abbott and Biorex to collaborate on bimoclomol development

Oct. 17, 1997

Novel protein tyrosine kinase inhibitors particularly useful for osteoporosis

Oct. 16, 1997

Clinical activity of policosanol reported

Oct. 16, 1997

Niaspan clinical activity reported at atherosclerosis symposium

Oct. 16, 1997

Lipogelosomes: a novel approach to lowering cholesterol

Oct. 16, 1997

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...